Will Leronlimab suffer world wide sales because of the FDA reputation for approving two drugs that marginally at best help patients? Prestigious British medical journal thinks it’s possible. PBS article yesterday link below:


https://www.npr.org/sections/coronavirus-live...rnal-urges